Exhibit 10.1


 


SECURITIES PURCHASE AGREEMENT


 


This Securities Purchase Agreement
(as amended, supplemented, restated and/or modified from time to time, this “Agreement”) is entered into as of October
26, 2021, by and between Siyata Mobile Inc., a British Columbia corporation (the “Company”), and Lind Global Fund II
LP, a Delaware limited partnership (the “Investor”).


 


BACKGROUND


 


A. The
board of directors (the “Board of Directors”) of the Company has authorized the issuance to Investor of the Note (as
defined below) and the Warrant (as defined below).


 


B. The
Investor desires to purchase the Note and the Warrant on the terms and conditions set forth in this Agreement.


 


C. Concurrently
with the execution of this Agreement, the Company, its Subsidiaries and the Investor will enter into certain security agreements and guarantees,
as listed in Exhibit A (the “Security Documents”), pursuant to which the Subsidiaries will guarantee all of the Company’s
obligations under the Transaction Documents and the Company and its Subsidiaries will grant a first priority security interest in substantially
all of their respective assets to secure the Company’s obligations hereunder and the Subsidiaries’ obligations under any such
guarantee.


 


NOW THEREFORE, in consideration
of the foregoing recitals and the covenants and agreements set forth herein, and other good and valuable consideration, the receipt and
sufficiency of which are hereby acknowledged, the Company and the Investor hereby agree as follows:


 


1. DEFINITIONS.
As used in this Agreement, the following terms shall have the following meanings specified or indicated below, and such meanings shall
be equally applicable to the singular and plural forms of such defined terms:


 


“1933 Act”
means the Securities Act of 1933, as amended.


 


“1934 Act”
means the Securities Exchange Act of 1934, as amended.


 


“Acquisition”
means the acquisition by the Company or any direct or indirect Subsidiary of the Company of a majority of the Equity Interests or substantially
all of the assets and business of any Person, whether by direct purchase of Equity Interests, asset purchase, merger, consolidation or
like combination.


 


“Affiliate”
means a Person that directly, or indirectly through one or more intermediaries, controls or is controlled by, or is under common control
with, the Person specified.


 




     


     

    

 


“Agreement”
has the meaning set forth in the preamble.


 


“Blue Sky Application”
has the meaning set forth in Section 9.3(a).


 


“Board of Directors”
has the meaning set forth in the recitals.


 


“Business Day”
means any day other than a Saturday, Sunday or any other day on which banks are permitted or required to be closed in New York City or
in Vancouver, British Columbia.


 


“Canadian Lock-Up
Period” means the period during which the Investor may not trade any of the Securities into Canada, being the period commencing
from the Closing Date and ending on the date that is four months and one calendar day after the Closing Date, provided that the relevant
provisions of NI 45-102 are otherwise complied with.


 


“Canadian Securities
Laws” means all applicable securities laws in each of the Provinces of British Columbia and Alberta, emanating from governmental
authorities, including the Canadian Securities Administrators, including the respective rules and regulations made thereunder together
with applicable published national and local instruments, policy statements, notices, blanket rulings and orders of the securities commissions
in British Columbia and Alberta, all as the same are in effect at the date hereof.


 


“Capital Stock”
means the Common Shares and any other classes of shares in the capital of the Company.


 


“Change of Control”
means, with respect to the Company, on or after the date of this Agreement:


 


		(a)	a change in the composition of the Board of Directors of the Company at a single shareholder meeting where
a majority of the individuals that were directors of the Company immediately prior to the start of such shareholder meeting are no longer
directors at the conclusion of such meeting, without prior written consent of the Investor;



 


		(b)	a change, without prior written consent of the Investor, in the composition of the Board of Directors
of the Company prior to the termination of this Agreement where a majority of the individuals that were directors as of the date of this
Agreement cease to be directors of the Company prior to the termination of this Agreement;



 


		(c)	other than a shareholder that holds such a position at the date of this Agreement, if a Person comes to
have beneficial ownership, control or direction over more than forty percent (40%) of the voting rights attached to any class of voting
securities of the Company; or



 


		(d)	the sale or other disposition by the Company or any of its Subsidiaries in a single transaction, or in
a series of transactions, of all or substantially all of their respective assets.



 


 



    2 


     

    

 





“Closing”
has the meaning set forth in Section 2.2.


 


“Closing Date”
has the meaning set forth in Section 2.2.


 


“Code”
has the meaning set forth in Section 2.1.


 


“Commitment Fee”
means an amount equal to One Hundred Eighty Thousand Dollars ($180,000).


 


“Common Shares”
means the common shares in the capital of the Company, each of which has no par value per share.


 


“Company”
has the meaning set forth in the preamble.


 


“Conversion Shares”
means the Common Shares issuable upon the full or any partial conversion of the Note.


 


“Effectiveness Period”
has the meaning set forth in Section 9.2(a).


 


“Equity Interests”
means and includes capital stock, membership interests and other similar equity securities, and shall also include equity-linked securities
including, but not limited to, warrants or options to purchase capital stock, membership interests or other equity interests.


 


“Event”
means any event, change, development, effect, condition, circumstance, matter, occurrence or state of facts.


 


“Event of Default”
has the meaning set forth in Section 7.1.


 


“Exempted Securities”
means (a) Common Shares or preferred shares or rights, warrants or options to purchase Common Shares or preferred shares issued in connection
with any Acquisition, (b) equity securities issued by reason of a dividend, stock split, split-up or other distribution on Common Shares,
(c) Common Shares or rights, warrants or options to purchase Common Shares issued to employees or directors of, or consultants or
advisors to, the Company or any of its Subsidiaries pursuant to a plan, agreement or arrangement approved by the Board of Directors (“Equity
Plans”), (d) Common Shares or rights, warrants or options to purchase Common Shares issued to third parties in connection with
strategic partnerships approved by the Board of Directors, (e) Common Shares actually issued upon the exercise of options or warrants
or Common Shares actually issued upon the conversion or exchange of any securities convertible into Common Shares, in each case provided
that such issuance is pursuant to the terms of the applicable option, warrant or convertible security, or (e) Common Shares issued upon
the exercise or conversion of options, warrants or convertible securities outstanding on the date hereof.


 


“Funding Amount”
means an amount equal to Six Million Dollars ($6,000,000).


 


“Governmental Entity”
means any instrumentality, subdivision, court, administrative agency, department, body, bureau, division, board, committee, panel,
commission, official or other authority of any country, state, province, prefect, municipality, locality or other government or political
subdivision thereof, whether domestic or foreign, or any supranational or multinational organization or authority, or any quasi-governmental,
private body or arbitral body exercising any executive, legislative, judicial, quasi-judicial, regulatory, taxing, importing, administrative
or other governmental or quasi-governmental authority.


 




    3 


     

    

  


“HSR Act”
has the meaning set forth in Section 5.16.


 


“IFRS”
means the International Financial Reporting Standards as issued by the International Accounting Standards Board and are subject to Canadian
auditing and auditor independence standards.


 


“Indebtedness”
has the meaning set forth in the Note.


 


“Investor”
has the meaning set forth in the preamble.


 


“Investor Group”
shall mean the Investor plus any other Person with which the Investor is considered to be part of a group under Section 13 of the 1934
Act or with which the Investor otherwise files reports under Sections 13 and/or 16 of the 1934 Act.


 


“Investor Party”
has the meaning set forth in Section 5.12(a).


 


“Investor Shares”
means the Conversion Shares, the Warrant Shares and any other shares issued or issuable to the Investor pursuant to this Agreement, the
Note or the Warrant.


 


“IP Rights”
has the meaning set forth in Section 3.10.


 


“Law” means
any law, rule, regulation, order, judgment or decree, including, without limitation, any federal, provincial and state securities laws,
including Canadian Securities Laws.


 


“Legend Removal Date”
has the meaning set forth in Section 5.1(c).


 


“Losses”
has the meaning set forth in Section 5.12(a).


 


“Material Adverse
Effect” means any material adverse effect on (i) the businesses, properties, assets, prospects, operations, results of operations
or financial condition of the Company, or the Company and the Subsidiaries, taken as a whole, or (ii) the ability of the Company to consummate
the transactions contemplated by this Agreement or to perform its obligations hereunder or under the Note or the Warrant; provided,
however, that none of the following shall be deemed either alone or in combination to constitute, and none of the following shall
be taken into account in determining whether there has been or would be, a Material Adverse Effect: (a) any adverse effect resulting
from or arising out of general economic or financial or capital markets or political conditions in the United States or in any other jurisdiction
in which the Company has operations or conducts business to the extent, and only to the extent, the effects do not disproportionately
affect the Company as compared to other participants in the industries in which the Company operates; (b) any adverse effect resulting
from or arising out of general conditions in the industries in which the Company and the Subsidiaries operate; (c) any adverse effect
resulting from any changes to applicable Law; or (d) any adverse effect resulting from or arising out of any natural disaster or
any acts of terrorism, sabotage, military action or war or any escalation or worsening thereof; provided, further, that
any event, occurrence, fact, condition or change referred to in clauses (a) through (d) immediately above shall be taken into account
in determining whether a Material Adverse Effect has occurred or could reasonably be expected to occur to the extent that such event,
occurrence, fact, condition or change has a disproportionate effect on the Company and/or the Subsidiaries compared to other participants
in the industries in which the Company and the Subsidiaries operate.


 




    4 


     

    

 


“Maximum Percentage”
means 4.99%; provided, that if at any time after the date hereof the Investor Group beneficially owns in excess of 4.99% of any
class of Equity Interests in the Company that is registered under the 1934 Act (excluding any Equity Interests deemed beneficially owned
by virtue of the Note and the Warrant), then the Maximum Percentage shall automatically increase to 9.99% so long as the Investor Group
owns in excess of 4.99% of such class of Equity Interests (and shall, for the avoidance of doubt, automatically decrease to 4.99% upon
the Investor Group ceasing to own in excess of 4.99% of such class of Equity Interests).


 


“Money Laundering
Laws” has the meaning set forth in Section 3.25.


 


“New Securities”
means, collectively, equity securities of the Company, whether or not currently authorized, as well as rights, options, or warrants to
purchase such equity securities, or securities of any type whatsoever that are, or may become, convertible or exchangeable into or exercisable
for such equity securities.


 


“NI 45-102”
means National Instrument 45-102 – Resale of Securities of the Canadian Securities Administrators.


 


“NI 45-106”
means National Instrument 45-106 – Prospectus Exemptions of the Canadian Securities Administrators.


 


“NI 51-102”
means National Instrument 45-102 – Continuous Disclosure Obligations of the Canadian Securities Administrators.


 


“Note“
has the meaning set forth in Section 2.1.


 


"Obligor”
means the Company and each of its Subsidiaries.


 


“OFAC”
has the meaning set forth in Section 3.23.


 


“Offer Notice“
has the meaning set forth in Section 10.1.


 


"Permitted Indebtedness”
shall have the meaning set forth in Section 5.8.


 


“Person”
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company,
joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.


 


“Prepayment Right”
shall have the meaning set forth in Section 2.4.


 


“Principal Amount”
has the meaning set forth in Section 2.1.


 


“Proceedings”
has the meaning set forth in Section 3.6.


 




    5 


     

    

 


“Prohibited Transaction”
means a transaction with a third party or third parties in which the Company issues or sells (or arranges or agrees to issue or sell):


 


(a) any
debt, equity or equity-linked securities (including options or warrants) that are convertible into, exchangeable or exercisable for, or
include the right to receive shares of the Company’s Capital Stock:


 


(i) at
a conversion, repayment, exercise or exchange rate or other price that is based on, and/or varies with, a discount to the
future trading prices of, or quotations for, Common Shares; or


 


(ii) at
a conversion, repayment, exercise or exchange rate or other price that is subject to being reset at some future date after the
initial issuance of such debt, equity or equity-linked security or upon the occurrence of specified or contingent events (other than warrants
that may be repriced by the Company); or


 


(b) any
securities in a capital or debt raising transaction or series of related transactions which grant to an investor the right to receive
additional securities based upon future transactions of the Company on terms more favorable than those granted to such investor in such
first transaction or series of related transactions;


 


and are deemed to include transactions generally
referred to as at-the-market transactions (ATMs) or equity lines of credit and stand-by equity distribution agreements, and convertible
securities and loans having a similar effect. Notwithstanding the foregoing, and for the avoidance of doubt, rights issuances, shareholder
purchase plans, Equity Plans, convertible securities, or issuances of Equity Interests, based on the trading price of the Common Shares
on the Trading Market but each at a fixed price per share, shall not be deemed to be a Prohibited Transaction.


 


“Prospectus” means the prospectus
included in any Registration Statement, as amended or supplemented by any prospectus supplement, with respect to the terms of the offering
of any portion of the Investor Shares covered by such Registration Statement and by all other amendments and supplements to the prospectus,
including post-effective amendments and all material incorporated by reference in such prospectus, and any “free writing prospectus”
as defined in Rule 405 under the 1933 Act.


 


“Public Record” has the meaning
set forth in Section 3.5(a).


 


“register,”
”registered” and “registration” refer to a registration made by preparing and filing a Registration
Statement or similar document in compliance with the 1933 Act (as defined below), and the declaration or ordering of effectiveness of
such Registration Statement or document.


 


“Registration Statement”
means any registration statement of the Company filed under the 1933 Act, including the Prospectus and amendments and supplements to such
Registration Statement, and including post-effective amendments, all exhibits and all material incorporated by reference in such Registration
Statement.


 




    6 


     

    

 


“Required Minimum”
means, as of any date, the maximum aggregate number of Common Shares then issued or potentially issuable in the future pursuant to the
Transaction Documents, including any Warrant Shares issuable upon exercise in full of all Warrants or Conversion Shares issuable upon
conversion in full of the Note, ignoring any conversion or exercise limits set forth therein.


 


“Reverse Split”
has the meaning set forth in Section 5.21.


 


“SEC” means
the United States Securities and Exchange Commission.


 


“Security Documents”
has the meaning set forth in the recitals.


 


“Securities”
means the Note, the Warrant and the Investor Shares.


 


“Securities Termination
Event” means either of the following has occurred:


 


(a) trading
in securities generally in the United States has been suspended or limited for a consecutive period of greater than three (3) Business
Days; or


 


(b) a
banking moratorium has been declared by the United States or the New York State authorities and is continuing for a consecutive period
of greater than three (3) Business Days.


 


“SEDAR”
means the System for Electronic Document Analysis and Retrieval of the Canadian Securities Administrators.


 


“Stockholder Approval”
shall mean the approval of the holders of a majority of the Company’s outstanding voting Common Shares: (a) if and to the extent
legally required, to amend the Company’s notice of articles to increase the number of authorized Common Shares by at least the number
of Common Shares equal to the number of Common Shares issuable hereunder, (b) to ratify and approve all of the transactions contemplated
by the Transaction Documents, including the issuance of all of the Investor Shares (as such term is defined in each of such documents)
issued and potentially issuable to the Investor thereunder, all as may be required by the applicable rules and regulations of the Trading
Market (or any successor entity).


 


“Subsidiary”
of a Person means a corporation, partnership, joint venture, limited liability company or other business entity of which a majority of
the shares of securities or other interests having ordinary voting power for the election of directors or other governing body (other
than securities or interests having such power only by reason of the happening of a contingency) are at the time beneficially owned, or
the management of which is otherwise controlled, directly, or indirectly through one or more intermediaries, or both, by such Person.
Unless otherwise specified, all references herein to a “Subsidiary” or to “Subsidiaries” shall refer to a Subsidiary
or Subsidiaries of the Company.


 


“Tax” or
“Taxes” means all federal United States and Canadian, provincial, state, municipal, foreign and other taxes (including,
without limitation, income taxes, sales taxes, excise taxes, value added taxes, capital taxes, property taxes, withholding taxes, payroll
taxes and contributions, and production, severance and similar taxes and assessments) and includes all penalties, interest and fines with
respect thereto and all liabilities for the payment of such amounts as a transferee or successor or under any obligation to indemnify
another Person.


 




    7 


     

    

  


“TD Bank Debt”
means the Company’s existing indebtedness arising out of its $750,000 CAD working capital facility with TD Bank pursuant to that
certain Demand Operating Facility Amendment Agreement, dated August 11, 2021.


 


“Trading Day”
means a day on which the Common Shares are traded on a Trading Market.


 


“Trading Market”
means whichever of the New York Stock Exchange, NYSE American, or the Nasdaq Stock Market (including the Nasdaq Capital Market), on which
the Common Shares are listed or quoted for trading on the date in question.


 


“Transaction Documents”
means this Agreement, the Note, the Warrant, the Security Documents, and any other documents or agreements executed or delivered by any
Obligor in connection with the transactions contemplated hereunder.


 


“VWAP”
means, as of any date, the price determined by the first of the following clauses that applies: (a) if the Common Shares are then listed
or quoted on a Trading Market, the daily volume weighted average price of one Common Share trading in the ordinary course of business
on the applicable trading price for such date (or the nearest preceding date) on such Trading Market as reported by Bloomberg Financial
L.P.; (b) if the Common Shares are not then listed on a Trading Market and if the Common Shares are traded in the over-the-counter market,
as reported by the OTCQX or OTCQB Markets, the volume weighted average price of one Common Share for such date (or the nearest preceding
date) on the OTCQX or OTCQB Markets, as reported by Bloomberg Financial L.P.; (c) if the Common Shares are not then listed or quoted on
a Trading Market or on the OTCQX or OTCQB Markets and if prices for the Common Shares are then reported in the “Pink Sheets”
published by the OTC Markets Group (or a similar organization or agency succeeding to its functions of reporting prices), the most recent
bid price of one Common Share so reported, as reported by Bloomberg Financial L.P.; or (d) in all other cases, the fair market value of
one Common Share as determined by an independent appraiser selected in good faith by the Holder and reasonably acceptable to the Company.


 


“Warrant"
has the meaning set forth in Section 2.1.


 


“Warrant Shares”
means the Common Shares issuable upon exercise of the Warrant.


 


2.
PURCHASE AND SALE OF THE NOTE AND THE WARRANT.


 


2.1
Purchase and Sale of the Note and the Warrant. Subject to the terms and conditions set forth herein, at the Closing,
the Company shall issue and sell to the Investor, and the Investor shall purchase from the Company, (a) a convertible promissory note,
in the form attached hereto as Exhibit B (the “Note”), in the principal amount of Seven Million Two Hundred
Thousand Dollars ($7,200,000), subject to adjustment as set forth in the Note (the “Principal Amount”) and (b) a Common
Share purchase warrant, in the form attached hereto as Exhibit C, registered in the name of the Investor, pursuant to which the
Investor shall have the right to acquire, 2,142,857 Common Shares (the “Warrant”), in exchange for the Funding Amount.
The Investor and the Company agree that for U.S. and Canadian federal income tax purposes and applicable state, provincial, municipal,
local and non-U.S. tax purposes, the Funding Amount shall be allocable between the Note and the Warrant based on the relative fair market
values thereof. Neither the Investor nor the Company shall take any contrary position on any tax return, or in any audit, claim, investigation,
inquiry or proceeding in respect of Taxes, unless otherwise required pursuant to a final determination within the meaning of Section 1313
of the Internal Revenue Code of 1986, as amended (the “Code”), or any analogous provision of applicable Canadian federal,
state, provincial or local law.


 




    8 


     

    

 


2.2
Closing. The closing hereunder, including payment for and delivery of the Note and the Warrant, shall take place remotely
via the exchange of documents and signatures, no later than ten (10) Business Days following the execution and delivery of this Agreement,
subject to satisfaction or waiver of the conditions set forth in Section 6, or at such other time and place as the Company and
the Investor agree upon, orally or in writing (the “Closing,” and the date of the Closing being the “Closing
Date”).


 


2.3 Commitment
Fee. At the Closing, the Company shall pay to the Investor the Commitment Fee, in United States dollars and in immediately available
funds. The Commitment Fee shall be paid by being offset against the Funding Amount payable by the Investor at Closing.


 


2.4 Prepayment
Right. As set forth in the Note, in its sole discretion and upon giving the prior written notice set forth in the Note, the Company
will have the right to pre-pay the entire then-outstanding principal amount of the Note at any time with no penalty or premium of any
kind (the “Prepayment Right“); provided, that in the event that the Company elects to exercise its Prepayment
Right, the Investor will have the option to convert up to twenty-five percent (25%) of the Principal Amount, at a price per share equal
to the lesser of the Repayment Share Price or the Conversion Price (as each such term is defined in the Note).


 


2.5 Senior
Obligation. As an inducement for the Investor to enter into this Agreement and to purchase the Note, all obligations of the Obligors
pursuant to the Transaction Documents shall be secured by a security interest in and lien upon substantially all of the assets of the
Obligors.


 


3. REPRESENTATIONS
AND WARRANTIES OF THE COMPANY. The Company represents and warrants to the Investor and covenants with the Investor that, except
as is set forth in the Disclosure Letter being delivered to the Investor as of the date hereof and as of the Closing Date, the following
representations and warranties are true and correct:


 


3.1
Organization and Qualification. The Company is a corporation duly organized and validly existing in good standing under
the Laws of the Province of British Columbia and has the requisite corporate power and authority to own its properties and to carry on
its business as now being conducted. The Company is duly qualified to do business and is in good standing in every jurisdiction in which
the ownership of its property or the nature of the business conducted by it makes such qualification necessary, except to the extent
that the failure to be so qualified or be in good standing would not have a Material Adverse Effect.


 




    9 


     

    

 


3.2
Authorization; Enforcement; Compliance with Other Instruments. The Company and each of its Subsidiaries (as applicable)
has the requisite corporate or limited liability company power, as the case may be, and authority to execute the Transaction Documents
to which it is a party, to issue and sell the Note and the Warrant pursuant hereto (in the case of the Company), and to perform its obligations
under the Transaction Documents to which it is a party, including issuing the Investor Shares on the terms set forth in this Agreement.
The execution and delivery of the Transaction Documents by the Company and its Subsidiaries and the issuance and sale of the Securities
by the Company pursuant hereto, including without limitation the reservation of the Conversion Shares and the Warrant Shares for future
issuance, have been duly and validly authorized by the Company’s Board of Directors and any similar governing body of a Subsidiary
and no further consent or authorization is required by the Company, its Subsidiaries, their respective Boards of Directors or other governing
bodies, the Company’s stockholders or any other Person in connection therewith. The Transaction Documents have been duly and validly
executed and delivered by the Company and its Subsidiaries party thereto and constitute valid and binding obligations of the Company
and its Subsidiaries (as applicable), enforceable against such parties in accordance with their respective terms, except as such enforceability
may be limited by general principles of equity or applicable bankruptcy, insolvency, reorganization, moratorium, liquidation or similar
Laws relating to, or affecting generally, the enforcement of creditors’ rights and remedies.


 


3.3
No Conflicts. The execution, delivery and performance of the Transaction Documents by the Company and its Subsidiaries
(as applicable) and the issuance and sale of the Note and the Warrant by the Company hereunder will not (a) conflict with or result in
a violation of the Company’s or its Subsidiaries’ notice of articles, articles or any other constating documents, (b) conflict
with, or constitute a default (or an event which, with notice or lapse of time or both, would become a default) under, or give to others
any right of termination, amendment, acceleration or cancellation of, any agreement to which the Company or any of the Subsidiaries is
a party, or require the Company or any Subsidiary to grant a lien or encumbrance on any of its property or assets under the terms of
any other agreement to which it is a party, or (c) subject to the making of the filings referred to in Section 5, violate
in any material respect any Law or any rule or regulation of the Trading Market applicable to the Company or any of the Subsidiaries
or by which any of their properties or assets are bound or affected. Assuming the accuracy of the Investor’s representations in
Section 4 and subject to the making of the filings referred to in Section 5, (i) no approval or authorization
will be required from any governmental authority or agency, regulatory or self-regulatory agency or other third party (including the
Trading Market) in connection with the issuance of the Note and the Warrant and the other transactions contemplated by this Agreement
(including the issuance of the Conversion Shares upon conversion of the Note and the Warrant Shares upon exercise of the Warrant) and
(ii) the issuance of the Note and the Warrant, and the issuance of the Conversion Shares upon the conversion of the Note and the
Warrant Shares upon exercise of the Warrant will be exempt from the registration and qualification requirements under the 1933 Act and
all applicable state securities Laws and from the prospectus requirements under applicable Canadian Securities Laws.


 






    10 


     

    

 


3.4
Capitalization and Subsidiaries.








 





(a) The
authorized Capital Stock of the Company consists of an unlimited number of Common Shares. As of the close of business on September 30,
2021, 4,821,191 Common Shares and no Preferred Shares were issued and outstanding. As of September 30, 2021, (x) an aggregate of 428,568
Common Shares are issuable upon exercise of options granted under a stock option plan, of which 226,196 are fully vested and exercisable;
and (y) an aggregate of 452,523 Common Shares are issuable upon exercise of agents’ options granted, of which 452,523 Common Shares
were exercisable as of September 30, 2021; and (z) an aggregate of 3,465,862 Common Shares are issuable upon exercise of outstanding warrants
granted by the Company, with exercise prices ranging from $6.85 to $70.56 per share. As of September 30, 2021, an aggregate of 2,011,089
Common Shares are issuable upon exercise of warrants traded on Nasdaq under the symbol “SYTAW” with an exercise price of $6.85.
The Company has duly reserved up to 720,000 Common Shares for issuance upon conversion of the Note (which assumes Conversion Shares (as
defined in the Note) are used to pay all principal installments under the Note) and has duly reserved 2,142,857 Common Shares for issuance
upon exercise of the Warrant. The Conversion Shares, when issued upon conversion of the Note in accordance with its terms, and the Warrant
Shares, if and when issued upon exercise of the Warrant in accordance with its terms, will be validly issued, fully paid and non-assessable
and free from all Taxes, liens and charges with respect to the issuance thereof. No shares of the Company’s Capital Stock are subject
to preemptive rights or any other similar rights or any liens or encumbrances suffered or permitted by the Company. The Company’s
notice of articles and articles on file on the SEC’s EDGAR website are true and correct copies of the Company’s constating
documents as in effect as of the date hereof. The Company is not in violation of any provision of its notice of articles or articles.


 


(b) Schedule
3.4(b) lists each direct and indirect Subsidiary of the Company existing on the date hereof and indicates for each Subsidiary (i)
the authorized capital stock or other Equity Interests of such Subsidiary as of the date hereof, (ii) the number and kind of shares or
other ownership interests of such Subsidiary that are issued and outstanding as of the date hereof, and (iii) the owner of such shares
or other ownership interests. No Subsidiary has any outstanding stock options, warrants or other instruments pursuant to which such Subsidiary
may at any time or under any circumstances be obligated to issue any shares of its capital stock or other Equity Interests. Each Subsidiary
is duly organized and validly existing in good standing under the laws of its jurisdiction of formation and has all requisite power and
authority to own its properties and to carry on its business as now being conducted.


 


(c) Neither
the Company nor any Subsidiary is bound by any agreement or arrangement pursuant to which it is obligated to register the sale of any
securities under the 1933 Act. There are no outstanding securities of the Company or any of the Subsidiaries which contain any redemption
or similar provisions, and there are no contracts, commitments, understandings or arrangements by which the Company or any Subsidiary
is or may become bound to redeem or purchase any security of the Company or any Subsidiary. There are no outstanding securities or instruments
containing anti-dilution or similar provisions that will be triggered by the issuance of the Note, the Warrant or the Investor Shares.
Neither the Company nor any Subsidiary has any stock appreciation rights or “phantom stock” plans or agreements or any similar
plan or agreement.


 


(d) The
issuance and sale of any of the Securities on the Closing Date will not obligate the Company to issue Common Shares or other securities
to any other Person and will not result in the adjustment of the exercise, conversion, exchange, or reset price of any outstanding securities.


 




    11 


     

    

 


(e) As
of the date of this Agreement, the Company has capacity under the rules and regulations of the Trading Market to issue up to 963,238 Common
Shares (or securities convertible into or exercisable for Common Shares) without obtaining Stockholder Approval.


 


3.5
Public Record; Financial Statements.


 


(a) As
of the date hereof, the Company has filed all reports, schedules, forms, statements and other documents required to be filed by it with
the Canadian Securities Administrators under applicable Canadian Securities Laws and pursuant to the reporting requirements of the 1934
Act (all of the foregoing filed prior to the date hereof and all exhibits included therein and financial statements and schedules thereto
and documents incorporated by reference therein being hereinafter referred to as the “Public Record”). As of their
respective filing dates, all documents filed by the Company in the Public Record complied in all material respects with the requirements
of applicable Canadian Securities Laws and the 1934 Act, as applicable, and the rules and regulations thereunder, and none of the documents
in the Public Record, at the time they were filed with the Canadian Securities Administrators or SEC, as applicable, contained any untrue
statement of a material fact or omitted to state a material fact required to be stated therein or necessary to make the statements therein,
in light of the circumstances under which they were made, not misleading.


 


(b) As
of their respective dates, the financial statements of the Company included in the Public Record complied as to form in all material respects
with applicable accounting requirements and the published rules and regulations of the Canadian Securities Administrators with respect
thereto. Such financial statements have been prepared in accordance with IFRS, and audited by a firm that is a member of the Canadian
Accounting Standards Board consistently applied, during the periods involved (except as may be otherwise indicated in such financial statements
or the notes thereto, or, in the case of unaudited interim statements, to the extent they may exclude footnotes or may be condensed or
summary statements) and fairly present in all material respects the consolidated financial position of the Company as of the dates thereof
and the consolidated results of its operations and consolidated cash flows for the periods then ended (subject, in the case of unaudited
statements, to normal year-end audit adjustments). No other written information provided by or on behalf of the Company to the Investor
in connection with the Investor’s purchase of the Note and the Warrant which is not included in the Public Record contains any untrue
statement of a material fact or omits to state any material fact necessary to make the statements therein, in the light of the circumstance
under which they are or were made, not misleading.


 


(c) Except
as set forth on Schedule 3.5(c), the Company and each of the Subsidiaries maintain a system of internal accounting controls sufficient
to provide reasonable assurance that (i) transactions are executed in accordance with management’s general or specific authorizations,
(ii) transactions are recorded as necessary to permit preparation of financial statements in conformity with IFRS and to maintain asset
accountability, (iii) reasonable controls to safeguard assets are in place and (iv) the recorded accountability for assets is compared
with the existing assets at reasonable intervals and appropriate action is taken with respect to any differences.]


 




    12 


     

    

 


3.6
Litigation and Regulatory Proceedings. Except as disclosed in the Public Record, there are no material actions, causes
of action, suits, claims, proceedings, inquiries or investigations (collectively, “Proceedings”) before or by any
court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the executive officers of
the Company or any of the Subsidiaries, threatened against or affecting the Company or any of the Subsidiaries, the Common Shares or
any other class of issued and outstanding shares of the Company’s Capital Stock, or any of the Company’s or the Subsidiaries’
officers or directors in their capacities as such and, to the knowledge of the executive officers of the Company, there is no reason
to believe that there is any basis for any such Proceeding.


 


3.7
No Undisclosed Events, Liabilities or Developments. Other than as set forth on Schedule 3.7 hereto, no event,
development or circumstance has occurred or exists, or to the knowledge of the executive officers of the Company is reasonably anticipated
to occur or exist that (a) would reasonably be anticipated to have a Material Adverse Effect or (b) would be required to be disclosed
by the Company under applicable securities Laws on a Registration Statement relating to an issuance and sale by the Company of its Common
Shares and which has not been publicly announced.


 


3.8
Compliance with Law. The Company and each of the Subsidiaries have conducted and are conducting their respective businesses
in compliance in all material respects with all applicable Laws and are in compliance in all material respects with the rules and regulations
of the Trading Market. The Company is not aware of any facts which could reasonably be anticipated to lead to a delisting of the Common
Shares by the Trading Market in the future.


 


3.9
Employee Relations. Neither the Company nor any Subsidiary is involved in any union labor dispute nor, to the knowledge
of the Company, is any such dispute threatened. Neither the Company nor any Subsidiary is a party to any collective bargaining agreement.
No executive officer as defined under Canadian Securities Laws has notified the Company that such officer intends to leave the Company’s
employ or otherwise terminate such officer’s employment with the Company.


 


3.10
Intellectual Property Rights. The Company and each Subsidiary owns or possesses adequate rights or licenses to use
all trademarks, trade names, service marks, service mark registrations, service names, patents, patent rights, copyrights, inventions,
licenses, approvals, governmental authorizations, trade secrets and other intellectual property rights (collectively, “IP Rights”)
necessary to conduct their respective businesses as now conducted. None of the material IP Rights of the Company or any of the Subsidiaries
are expected to expire or terminate within three (3) years from the date of this Agreement. Neither the Company nor any Subsidiary is
infringing, misappropriating or otherwise violating any IP Rights of any other Person. No claim has been asserted, and no Proceeding
is pending, against the Company or any Subsidiary alleging that the Company or any Subsidiary is infringing, misappropriating or otherwise
violating the IP Rights of any other Person, and, to the Company’s knowledge, no such claim or Proceeding is threatened, and the
Company is not aware of any facts or circumstances which might give rise to any such claim or Proceeding. The Company and the Subsidiaries
have taken commercially reasonable security measures to protect the secrecy, confidentiality and value of all of their material IP Rights.


 




    13 


     

    

 


3.11
Environmental Laws. Except, in each case, as would not be reasonably anticipated to have a Material Adverse Effect,
the Company and the Subsidiaries (a) are in compliance in all material respects with any and all applicable Laws relating to the protection
of human health and safety, the environment or hazardous or toxic substances or wastes, pollutants or contaminants, (b) have received
and hold all permits, licenses or other approvals required of them under all such Laws to conduct their respective businesses and (c)
are in compliance in all material respects with all terms and conditions of any such permit, license or approval.


 


3.12
Title to Assets. The Company and the Subsidiaries have good and marketable title to all personal property owned by
them which is material to their respective businesses, in each case free and clear of all liens, encumbrances and defects except those
set forth on Schedule 3.12. Any real property and facilities held under lease by the Company or any Subsidiary are held under
valid, subsisting and enforceable leases with such exceptions as are not material and do not interfere with the use made and proposed
to be made of such property and buildings by the Company and the Subsidiaries.


 


3.13
Insurance. The Company and each of the Subsidiaries are insured by insurers of recognized financial responsibility
against such losses and risks and in such amounts as management of the Company reasonably believes to be prudent and customary in the
businesses in which the Company and the Subsidiaries are engaged. Neither the Company nor any of the Subsidiaries has been refused any
insurance coverage sought or applied for, and the Company has no reason to believe that it will not be able to renew all existing insurance
coverage as and when such coverage expires or to obtain similar coverage from similar insurers.


 


3.14
Regulatory Permits. The Company and the Subsidiaries have in full force and effect all certificates, approvals, authorizations
and permits from all regulatory authorities and agencies necessary to own, lease or operate their respective properties and assets and
conduct their respective businesses, and neither the Company nor any Subsidiary has received any notice of Proceedings relating to the
revocation or modification of any such certificate, approval, authorization or permit, except for such certificates, approvals, authorizations
or permits with respect to which the failure to hold would not reasonably be expected to have, individually or in the aggregate, a Material
Adverse Effect.


 


3.15
No Materially Adverse Contracts, Etc. Neither the Company nor any of the Subsidiaries is (a) subject to any charter,
corporate or other legal restriction, or any judgment, decree or order which in the judgment of the Company’s officers has or is
expected in the future to have a Material Adverse Effect or (b) a party to any contract or agreement which in the judgment of the Company’s
management has or would reasonably be anticipated to have a Material Adverse Effect.


 




    14 


     

    

 


3.16
Taxes. The Company and the Subsidiaries each has correctly prepared and duly and timely made or filed, or caused to
be made or filed, all United States federal, and applicable state, provincial, local and non-U.S. Tax returns, reports and declarations
required by any jurisdiction to which it is subject and has paid all Taxes and other governmental assessments and charges that are material
in amount, required to be paid by it, regardless of whether such amounts are shown or determined to be due on such returns, reports and
declarations, except those being contested in good faith by appropriate proceedings and for which it has set aside on its books provision
reasonably adequate for the payment of all Taxes for periods subsequent to the periods to which such returns, reports or declarations
apply. There are no unpaid Taxes in any material amount claimed to be due by the taxing authority of any jurisdiction, and, to the knowledge
of the Company, there is no basis for any such claim. Each of the Company and the Subsidiaries has collected, withheld and remitted all
Taxes due and payable to the property taxing or other governmental authority. There are no audits, assessments, reassessments, suits,
proceedings, investigations or claims pending against the Company or any of the Subsidiaries in respect of Taxes paid or payable, and
there are no matters under discussion with any taxing or governmental authority of any jurisdiction involving the Company or any Subsidiary
with, or the subject of any agreement with, any taxing or governmental authority relating to claims for additional Taxes. There are no
agreements, waivers or other arrangements providing for an extension of time with respect to the assessment or reassessment of any Tax
owing by the Company or any subsidiary, the filing of any tax returns by the Company or any Subsidiary or the payment of any Tax by the
Company or any Subsidiary.


 


3.17 Solvency.
After giving effect to the receipt by the Company of the proceeds from the transactions contemplated by this Agreement (a) the Company’s
fair saleable value of its assets exceeds the amount that will be required to be paid on or in respect of the Company’s existing
debts and other liabilities (including known contingent liabilities) as they mature; and (b) the current cash flow of the Company,
together with the proceeds the Company would receive, were it to liquidate all of its assets, after taking into account all anticipated
uses of the cash, would be sufficient to pay all amounts on or in respect of its debt when such amounts are required to be paid. The Company
does not intend to incur debts beyond its ability to pay such debts as they mature (taking into account the timing and amounts of cash
to be payable on or in respect of its debt). The Company has no knowledge of any facts or circumstances which lead it to believe that
it will file for reorganization or liquidation under the bankruptcy or reorganization laws of any jurisdiction.


 


3.18 Investment
Company. The Company is not, and is not an Affiliate of, an “investment company” within the meaning of the Investment
Company Act of 1940, as amended.


 


3.19
Certain Transactions. Other than employment or consultant agreements or as disclosed in the Public Record, there are
no contracts, transactions, arrangements or understandings between the Company or any of its Subsidiaries, on the one hand, and any director,
officer or employee thereof on the other hand.


 


3.20
No General Solicitation. Neither the Company, nor any of its Affiliates, nor any person acting on its behalf, has engaged
in any form of general solicitation or general advertising (within the meaning of Regulation D) in connection with the offer or sale
of the Note or the Warrant pursuant to this Agreement.


 


3.21
Acknowledgment Regarding the Investor’s Purchase of the Note and the Warrant. The Company’s Board of Directors
has approved the execution of the Transaction Documents and the issuance and sale of the Note and the Warrant, based on its own independent
evaluation and determination that the terms of the Transaction Documents are reasonable and fair to the Company and in the best interests
of the Company and its stockholders. The Company and each of its Subsidiaries are entering into this Agreement and the Security Documents
to which they are party, and the Company is issuing and selling the Note and the Warrant, voluntarily and without economic duress. The
Company has had independent legal counsel of its own choosing review the Transaction Documents and advise the Company with respect thereto.
The Company acknowledges and agrees that the Investor is acting solely in the capacity of an arm’s length purchaser with respect
to the Note and the Warrant and the transactions contemplated hereby and that neither the Investor nor any person affiliated with the
Investor is acting as a financial advisor to, or a fiduciary of, the Company (or in any similar capacity) with respect to execution of
the Transaction Documents or the issuance of the Note and the Warrant or any other transaction contemplated hereby.


 




    15 


     

    

 


3.22
No Brokers’, Finders’ or Other Advisory Fees or Commissions. Other than a payment of two hundred ten thousand
dollars ($210,000) to ThinkEquity LLC, which provided advisory services to the Company, and which amount shall be paid by the Investor
directly to ThinkEquity LLC and be offset against the Funding Amount payable by the Investor at Closing, no brokers, finders or other
similar advisory fees or commissions will be payable by the Company or any Subsidiary or by any of their respective agents with respect
to the issuance of the Note or any of the other transactions contemplated by this Agreement.


 


3.23 OFAC.
None of the Company nor any of the Subsidiaries nor, to the best knowledge of the Company, any director, officer, agent, employee, affiliate
or person acting on behalf of the Company and/or any Subsidiary has been or is currently subject to any United States sanctions administered
by the Office of Foreign Assets Control of the United States Department of the Treasury (“OFAC”); and the Company will
not directly or indirectly use any proceeds received from the Investor, or lend, contribute or otherwise make available such proceeds
to its Subsidiaries or to any affiliated entity, joint venture partner or other person or entity, to finance any investments in, or make
any payments to, any country or person currently subject to any of the sanctions of the United States administered by OFAC.


 


3.24 No
Foreign Corrupt Practices. None of the Company or any of the Subsidiaries has, directly or indirectly: (a) made or authorized any
contribution, payment or gift of funds or property to any official, employee or agent of any governmental authority of any jurisdiction
except as otherwise permitted under applicable Law; or (b) made any contribution to any candidate for public office, in either case, where
either the payment or the purpose of such contribution, payment or gift was, is, or would be prohibited under the Foreign Corrupt Practices
Act, the Corruption of Foreign Public Officials Act (Canada) or the rules and regulations promulgated thereunder or under any other legislation
of any relevant jurisdiction covering a similar subject matter applicable to the Company or its Subsidiaries and their respective operations
and the Company has instituted and maintained policies and procedures designed to ensure, and which are reasonably expected to continue
to ensure, continued compliance with such legislation.


 


3.25 Anti-Money
Laundering. The operations of each of the Company and the Subsidiaries are and have been conducted at all times in compliance with
all applicable anti-money laundering laws, regulations, rules and guidelines in its jurisdiction of incorporation and in each other jurisdiction
in which such entity, as the case may be, conducts business (collectively, the “Money Laundering Laws”) and no action,
suit or proceeding by or before any court or governmental authority involving the Company or its Subsidiaries with respect to any of the
Money Laundering Laws is, to the best knowledge of the Company, pending, threatened or contemplated.


 




    16 


     

    

 


3.26 Disclosure.
The Company confirms that neither it, nor to its knowledge, any other Person acting on its behalf has provided the Investor or its agents
or counsel with any information that the Company believes constitutes material, non-public information. The Company understands and confirms
that the Investor will rely on the foregoing representations and covenants in effecting transactions in securities of the Company. All
disclosures provided to the Investor regarding the Company, its business and the transactions contemplated hereby, furnished by or on
behalf of the Company (including the Company’s representations and warranties set forth in this Agreement) are true and correct
in all material respects and do not contain any untrue statement of a material fact or omit to state any material fact necessary in order
to make the statements made therein, in light of the circumstances under which they were made, not misleading.


 


3.27 Residence.
The Company is not a non-resident of Canada for the purposes of the Income Tax Act (Canada).


 


4. REPRESENTATIONS
AND WARRANTIES OF THE INVESTOR. The Investor represents and warrants to the Company as follows:


 


4.1
Organization and Qualification. The Investor is a limited partnership, duly organized and validly existing in good
standing under the laws of the State of Delaware.


 


4.2
Authorization; Enforcement; Compliance with Other Instruments. The Investor has the requisite power and authority to
enter into and to perform its obligations under the Transaction Documents to which it is a party. The execution and delivery by the Investor
of the Transaction Documents to which it is a party have been duly and validly authorized by the Investor’s governing body and
no further consent or authorization is required. The Transaction Documents to which it is a party have been duly and validly executed
and delivered by the Investor and constitute valid and binding obligations of the Investor, enforceable against the Investor in accordance
with their terms, except as such enforceability may be limited by general principles of equity or applicable bankruptcy, insolvency,
reorganization, moratorium, liquidation or similar laws relating to, or affecting generally, the enforcement of creditors’ rights
and remedies.


 


4.3
No Conflicts. The execution, delivery and performance of the Transaction Documents to which it is a party by the Investor
and the purchase of the Note and the Warrant by the Investor will not (a) conflict with or result in a violation of the Investor’s
organizational documents, (b) conflict with, or constitute a material default (or an event which, with notice or lapse of time or both,
would become a material default) under, or give to others any rights of termination, amendment, acceleration or cancellation of, any
material agreement, contract, indenture mortgage, indebtedness or instrument to which the Investor is a party, or (c) violate any Law
applicable to the Investor or by which any of the Investor’s properties or assets are bound or affected. No approval or authorization
will be required from any governmental authority or agency, regulatory or self-regulatory agency or other third party in connection with
the purchase of the Note and the Warrant and the other transactions contemplated by this Agreement.


 




    17 


     

    

 


4.4
Investment Intent; Accredited Investor. The Investor is purchasing the Note and the Warrant for its own account, for
investment purposes, and not with a view towards distribution. The Investor is an “accredited investor” as such term is defined
in Rule 501(a) of Regulation D of the 1933 Act and as such term is defined in NI 45-106. The Investor has, by reason of its business
and financial experience, such knowledge, sophistication and experience in financial and business matters and in making investment decisions
of this type that it is capable of (a) evaluating the merits and risks of an investment in the Note, the Warrant and the Investor Shares
and making an informed investment decision, (b) protecting its own interests and (c) bearing the economic risk of such investment for
an indefinite period of time.


 


4.5
Opportunity to Discuss. The Investor has received all materials relating to the business, finance and operations of
the Company and the Subsidiaries as it has requested and has had an opportunity to discuss the business, management and financial affairs
of the Company and the Subsidiaries with the Company’s management. In making its investment decision, the Investor has relied solely
on its own due diligence performed on the Company by its own representatives.


 


4.6
No Governmental Review. The Investor understands that no Government Entity has passed on or made any recommendation
or endorsement of the Securities or the fairness or suitability of the investment in the Securities nor have such authorities passed
upon or endorsed the merits of the offering of the Securities.


 


4.7
No Other Representations.Except for the representations and warranties set forth in this Agreement and in other
Transaction Documents, the Investor makes no other representations or warranties to the Company.


 


5. OTHER
AGREEMENTS OF THE PARTIES.


 


5.1 Canadian
Lock-Up Period


 


(a) During
the Canadian Lock-Up Period, Securities may only be sold, transferred, assigned or otherwise disposed of pursuant to an applicable prospectus
exemption under applicable Canadian Securities Laws or outside of Canada in compliance with any applicable Laws.


 


(b) Certificates
evidencing the Securities will bear the following legend during the Canadian Lock-Up Period:


 


“UNLESS PERMITTED
UNDER SECURITIES LEGISLATION, THE HOLDER OF THIS SECURITY [AND OF ANY SECURITY ISSUED ON EXERCISE HEREOF] MUST NOT TRADE THE SECURITY
BEFORE FEBRUARY 28, 2022”


 


(c) Following
the Canadian Lock-Up Period, the Investor is entitled to have the legends previously required under Canadian Securities Laws removed from
any previously issued Securities, which the Company undertakes to cause within five (5) Business Days of any request from the Investor,
which request shall be accompanied by each applicable certificate representing the Securities in respect of which the request is made.


 






    18 


     

    

 


5.2 Legends,
etc.


 


(a) Securities
may only be disposed of pursuant to an effective Registration Statement, to the Company or pursuant to an available exemption from or
in a transaction not subject to the registration requirements of the 1933 Act, and in compliance with any applicable state securities
laws.


 


(b) Certificates
evidencing the Securities will contain the following legend, so long as is required by this Section 5.2(b) or Section 5.2(c):


 


[NEITHER THESE SECURITIES
NOR THE SECURITIES ISSUABLE UPON EXERCISE OF THESE SECURITIES HAVE BEEN REGISTERED] [THESE SECURITIES HAVE NOT BEEN REGISTERED] WITH THE
SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE
SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO
AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT
TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL
OPINION OF COUNSEL TO THE TRANSFEROR TO SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY ACCEPTABLE TO THE COMPANY. [THESE SECURITIES
AND THE SECURITIES ISSUABLE UPON EXERCISE OF THESE SECURITIES] [THESE SECURITIES] MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN
ACCOUNT SECURED BY SUCH SECURITIES.


 


The Company acknowledges and
agrees that the Investor may from time to time pledge, and/or grant a security interest in some or all of the Securities, in accordance
with applicable securities laws, pursuant to a bona fide margin agreement in connection with a bona fide margin account and, if required
under the terms of such agreement or account, the Investor may transfer pledged or secured Securities to the pledgees or secured parties.
Such a pledge or transfer would not be subject to approval or consent of the Company and no legal opinion of legal counsel to the pledgee,
secured party or pledgor shall be required in connection with the pledge, but such legal opinion may be required in connection with a
subsequent transfer following default by the Investor transferee of the pledge. No notice shall be required of such pledge. At the Company’s
expense, the Company will execute and deliver such reasonable documentation as a pledgee or secured party of Securities may reasonably
request in connection with a pledge or transfer of the Securities including the preparation and filing of any required prospectus supplement
under Rule 424(b)(3) of the 1933 Act or other applicable provision of the 1933 Act to appropriately amend the list of selling stockholders
thereunder.


 




    19 


     

    

 


(c) Certificates
evidencing the Investor Shares shall not contain any legend (including the legend set forth in Section 5.2(b)): (i) while a Registration
Statement covering the Investor Shares is effective under the 1933 Act, (ii) following any sale of such Investor Shares pursuant to Rule
144, (iii) while such Investor Shares are eligible for sale without restriction under Rule 144, or (iv) if such legend is not required
under applicable requirements of the 1933 Act (including judicial interpretations and pronouncements issued by the Staff of the SEC).
The Company shall cause its counsel to issue any legal opinion or instruction required by the Company’s transfer agent to comply
with the requirements set forth in this Section. At such time as a legend is no longer required for the Investor Shares under this Section
5.2(c), the Company will, no later than three (3) Business Days following the delivery by the Investor to the Company or the Company’s
transfer agent of a certificate representing Investor Shares containing a restrictive legend (such third Business Day, the “Legend
Removal Date”), deliver or cause to be delivered to the Investor a certificate representing such Investor Shares that is free
from all restrictive and other legends. In addition to any other remedies available to the Investor, the Company shall pay to the Investor,
in cash, as partial liquidated damages and not as a penalty, for each $1,000 of Investor Shares (based on the VWAP of the Common Shares
on the date such Investor Shares are submitted to the Company or the Company’s transfer agent) delivered for removal of the restrictive
or other legend, $5 per Trading Day for each Trading Day after the Legend Removal Date until such Investor Shares are delivered without
a legend.  The Company may not make any notation on its records or give instructions to any transfer agent of the Company that enlarge
the restrictions on transfer set forth in this Section except as it may reasonably determine are necessary or appropriate to comply or
to ensure compliance with those applicable laws that are enacted or modified after the Closing.


 


5.3 Furnishing
of Information. As long as the Investor owns the Securities, the Company covenants to timely file (or obtain extensions in respect
thereof and file within the applicable grace period) all reports required to be filed by the Company after the date hereof pursuant to
the 1934 Act. As long as the Investor owns the Securities, if the Company is not required to file reports pursuant to such laws, it will
prepare and furnish to the Investor and make publicly available in accordance with Rule 144(c) such information as is required for the
Investor to sell the Investor Shares under Rule 144. The Company further covenants that it will take such further action as any holder
of Securities may reasonably request, all to the extent required from time to time to enable such Person to sell such Investor Shares
without registration under the 1933 Act within the limitation of the exemptions provided by Rule 144 or other applicable exemptions.


 


5.4 Integration.
The Company shall not, and shall use its best efforts to ensure that no Affiliate of the Company shall, sell, offer for sale or solicit
offers to buy or otherwise negotiate in respect of any security (as defined in Section 2 of the 1933 Act) that will be integrated with
the offer or sale of the Securities in a manner that would require the registration under the 1933 Act of the sale of the Securities to
the Investor, or that will be integrated with the offer or sale of the Securities for purposes of the rules and regulations of any Trading
Market that would require, under the rules of the Trading Market, the Stockholder Approval.


 


5.5 Notification
of Certain Events. The Company shall give prompt written notice to the Investor of (a) the occurrence or non-occurrence of any
Event, the occurrence or non-occurrence of which would render any representation or warranty of the Company contained in this Agreement
or any other Transaction Document, if made on or immediately following the date of such Event, untrue or inaccurate in any material respect,
(b) the occurrence of any Event that, individually or in combination with any other Events, has had or could reasonably be expected
to have a Material Adverse Effect, (c) any failure of the Company to comply with or satisfy any covenant or agreement to be complied
with or satisfied by it hereunder or any Event that would otherwise result in the nonfulfillment of any of the conditions to the Investor’s
obligations hereunder, (d) any notice or other communication from any Person alleging that the consent of such Person is or may be
required in connection with the consummation of the transactions contemplated by this Agreement or any other Transaction Document, or
(e) any Proceeding pending or, to the Company’s knowledge, threatened against a party relating to the transactions contemplated
by this Agreement or any other Transaction Document.


 




    20 


     

    

 


5.6
Available Stock. The Company shall at all times keep authorized and reserved and available for issuance, free of preemptive
rights, such number of Common Shares as are issuable upon conversion of the Note and exercise of the Warrant at any time. If the Company
determines at any time that it does not have a sufficient number of authorized Common Shares to reserve and keep available for issuance
as described in this Section 5.6, the Company shall use all commercially reasonable efforts to increase the number of authorized
Common Shares by seeking Stockholder Approval for the authorization of such additional shares.


 


5.7
Use of Proceeds. The Company will use the proceeds from the sale of the Note and the Warrant for the repayment of the
Exisiting Debt (as defined below), and, thereafter, for general working capital purposes.


 


5.8 Repayment
of Note. Other than as set forth on Schedule 5.7, neither the Company nor any Subsidiary has outstanding any Indebtedness (all such
Indebtedness set forth on Schedule 5.7 is hereinafter referred to as the “Existing Debt”; the Existing Debt and any Indebtedness
which constitutes the Working Capital Facility (as such term is defined in the Note) and satisfies all of the requirements of a Working
Capital Facility set forth in the Note are collectively referred to herein as the “Permitted Indebtedness”). The Company shall
not make any voluntary cash prepayments on any Indebtedness at any time while any amounts are owing under the Note other than (a) with
respect to the Existing Debt, cash payments the Company is required to make pursuant to the express terms thereof existing on the date
hereof and (b) with respect to the Working Capital Facility, pursuant to the express terms of the Intercreditor Agreement (as such term
is defined in the Note). If the Company or any Subsidiary issues any Indebtedness other than the Permitted Indebtedness, after obtaining
the written consent of the Investor pursuant to Section 1.10 of the Note, including any subordinated Indebtedness or convertible Indebtedness
(other than the Note), other than Exempted Securities, then unless otherwise waived in writing by and at the discretion of the Investor,
the Company will immediately utilize the proceeds of such issuance (or cause such Subsidiary to immediately utilize the proceeds of such
issuance) to repay the Note. If the Company issues any Equity Interests, other than Exempted Securities, for aggregate proceeds to the
Company of greater than $10,000,000, excluding offering costs or other expenses, unless otherwise waived in writing by and at the discretion
of the Investor, the Company will direct 20% of such proceeds from such issuance to repay the Note. Any such repayment of the Note shall
be made without premium or penalty.


 


5.9 Intercreditor
Agreement. In the event that the Company or any Subsidiary incurs Indebtedness after obtaining the written consent of the Investor
pursuant to Section 1.10 of the Note or issues convertible debt securities to a seller as partial consideration paid to such seller in
connection with an Acquisition, unless otherwise waived in writing by the Investor, as a condition to consummation of such Acquisition,
the holder of such Indebtedness or convertible debt securities shall enter into an intercreditor agreement with the Company and the Investor
on terms reasonably satisfactory to the Investor.


 




    21 


     

    

 


5.10
Prohibited Transactions. The Company hereby covenants and agrees not to enter into any Prohibited Transactions without the
Investor’s prior written consent, until (30) days after such time as the Note has been repaid in full and/or has been converted
into Conversion Shares.


 


5.11
Securities Laws Disclosure; Publicity. The Company shall, by 9:00 a.m. (New York City time) on the Trading Day immediately
following the date hereof, issue a press release disclosing the material terms of the transactions contemplated hereby, and shall, within
ten (10) days following the date hereof, file a material change report in accordance with NI 51-102 and Current Report on Form 6-K disclosing
the material terms of the transactions contemplated hereby and file a copy of this Agreement on SEDAR; provided, that the Company may
not issue such press release or file such material change report without the Investor’s prior written consent. The Company shall
not issue any press release nor otherwise make any such public statement regarding the Investor or the Transaction Documents without
the prior written consent of the Investor, except if such disclosure is required by law, in which case the Company shall (a) ensure that
such disclosure is restricted and limited in content and scope to the maximum extent permitted by Law to meet the relevant disclosure
requirement and (b) provide a copy of the proposed disclosure to the Investor for review prior to release and the Company shall incorporate
the Investor’s reasonable comments. Following the execution of this Agreement, the Investor and its Affiliates and/or advisors
may place announcements on their respective corporate websites and in financial and other newspapers and publications (including, without
limitation, customary “tombstone” advertisements) describing the Investor’s relationship with the Company under this
Agreement and including the name and corporate logo of the Company. Notwithstanding anything herein to the contrary, to comply with United
States Treasury Regulations Section 1.6011-4(b)(3)(i), each of the Company and the Investor, and each employee, representative or other
agent of the Company or the Investor, may disclose to any and all persons, without limitation of any kind, the U.S. federal and state
income tax treatment, and the U.S. federal and state income tax structure, of the transactions contemplated hereby and all materials
of any kind (including opinions or other tax analyses) that are provided to such party relating to such tax treatment and tax structure
insofar as such treatment and/or structure relates to a U.S. federal or state income tax strategy provided to such recipient.


 


5.12
Indemnification of the Investor.


 


(a)
The Company will indemnify and hold the Investor, its Affiliates and their respective directors, officers, managers, shareholders, members,
partners, employees and agents and permitted successors and assigns (each, an “Investor Party”) harmless from any
and all losses, liabilities, obligations, claims, contingencies, damages, costs and expenses, including all judgments, amounts paid in
settlements, court costs and reasonable attorneys’ fees and costs of investigation and defense (collectively, “Losses”)
that any such Investor Party may suffer or incur as a result of or relating to:


 


(i)
any breach or inaccuracy of any representation, warranty, covenant or agreement made by the Company in any Transaction Document;


 


(ii)
any misrepresentation made by the Company in any Transaction Document or in any Public Record document;


 






    22 


     

    




 


(iii)
any omission to state any material fact necessary in order to make the statements made in any Public Record, in light of the circumstances
under which they were made, not misleading;


 


(iv)
any Proceeding before or by any court, public board, government agency, self-regulatory organization or body based upon, or resulting
from the execution, delivery, performance or enforcement of any of the Transaction Documents or the consummation of the transactions
contemplated thereby, and whether or not the Investor is party thereto by claim, counterclaim, crossclaim, as a defendant or otherwise,
or if such Proceeding is based upon, or results from, any of the items set forth in clauses (i) through (iii) above.


 


(b)
In addition to the indemnity contained herein, the Company will reimburse each Investor Party for its reasonable legal and other expenses
(including the cost of any investigation, preparation and travel in connection therewith) incurred in connection therewith, as such expenses
are incurred.


 


(c)
The provisions of this Section 5.12 shall survive the termination or expiration of this Agreement.


 


5.13
Non-Public Information. The Company covenants and agrees that neither it nor any other Person acting on its behalf will provide
the Investor or its agents or counsel with any information that the Company believes constitutes material, non-public information. To
the extent the Company does not comply with this covenant and provides the Investor with material, non-public information, the Company
shall publicly disclose such information within seventy two (72) hours of providing the information to the Investor; provided, however,
in the event that such material non-public information is provided to Investor pursuant to Section 10, the Company shall publicly
disclose such information within twenty (20) Business Days of providing the information to the Investor. The Company understands and
confirms that the Investor shall be relying on the foregoing representation in effecting transactions in securities of the Company.


 


5.14
Stockholder Approval. The Company shall hold a special meeting of shareholders (which may also be at the annual meeting of
shareholders) on or before the 90th calendar day following the date hereof for the purpose of obtaining the Shareholder Approval; provided,
however, such ninety (90) calendar days shall be increased to one hundred twenty (120) calendar days in the event the Company receives
comments to its proxy statement from the SEC, with the recommendation of the Board of Directors that such proposal be approved, and the
Company shall solicit proxies from its shareholders in connection therewith in the same manner as all other management proposals in such
proxy statement and all management-appointed proxyholders shall vote their proxies in favor of such proposal. If the Company does not
obtain Shareholder Approval at the first meeting, the Company shall call a meeting every four months thereafter to seek Shareholder Approval
until the date the Shareholder Approval is obtained. Prior to any such shareholder meeting, the Company shall timely file a proxy circular
pursuant to NI 51-102 in compliance in all material respects with the provisions of the Company’s constating documents and all
applicable Law.


 






    23 


     

    

 


5.15
Listing of Securities. The Company shall: (a) in the time and manner required by each Trading Market on which the Common Shares
are listed, prepare and file with such Trading Market an additional shares listing application covering the Investor Shares, (b) take
all steps necessary to cause such Common Shares to be approved for listing on each Trading Market on which the Common Shares are listed
as soon as possible thereafter, (c) provide to the Investor evidence of such listing, and (d) maintain the listing of such shares on
each such Trading Market.


 


5.16
Antitrust Notification. If the Investor determines, in its sole judgment and upon the advice of counsel, that the issuance
of the Note, the Warrant or the Investor Shares pursuant to the terms hereof would be subject to the provisions of the Hart-Scott-Rodino
Antitrust Improvements Act of 1976, as amended (the “HSR Act”), the Company shall file as soon as practicable after
the date on which the Company receives notice from the Investor of the applicability of the HSR Act and a request to so file with the
United States Federal Trade Commission and the United States Department of Justice the notification and report form required to be filed
by it pursuant to the HSR Act in connection with such issuance.


 


5.17
Change of Prime Broker, Custodian. The Investor has informed the Company of the names of its prime broker and its share custodian.
The Investor shall notify the Company of any change in its prime broker or share custodian within three (3) Business Days of such change
having taken effect.


 


5.18
Share Transfer Agent. The Company has informed the Investor of the name of its share transfer agent and represents and warrants
that the transfer agent participates in the Depository Trust Company Fast Automated Securities Transfer program. The Company shall not
change its share transfer agent without the prior written consent of the Investor.


 


5.19
[Reserved.]


 


5.20
Set-Off.


 


(a)
The Investor may set off any of its obligations to the Company (whether or not due for payment), against any of the Company’s obligations
to the Investor (whether or not due for payment) under this Agreement and/or any other Transaction Document.


 


(b)
The Investor may do anything necessary to effect any set-off undertaken in accordance with this Section 5.20 (including varying
the date for payment of any amount payable by the Investor to the Company).


 


5.21
Reverse Stock Split. If at any time the last closing trade price for the Common Shares on the Trading Market as reported by
the Trading Market is less than $1.00, the Company shall promptly call a meeting of the stockholders of the Company for purposes of approving
a reverse stock split of the Common Shares such that the trade price of the Common Shares will be at least $2.00 (a “Reverse
Split”) and, subject to receipt of stockholder approval, shall use its best efforts to promptly effect a Reverse Split. The
Investor acknowledges that the Company can make no guarantees regarding whether it will be successful in receiving Stockholder Approval
to effect any such Reverse Split.


 






    24 


     

    

 


6.
CLOSING CONDITIONS


 


6.1
Conditions Precedent to the Obligations of the Investor. The obligation of the Investor to fund the Note and acquire the Warrant
at the Closing is subject to the satisfaction or waiver by the Investor, at or before such Closing, of each of the following conditions:


 


(a)
Required Documentation. The Company must have delivered to the Investor copies of all resolutions duly adopted by the Board of
Directors of the Company, or any such other documentation of the Company approving the Agreement, the Transaction Documents and any of
the transactions contemplated hereby or thereby;


 


(b)
Consents and Permits. The Company must have obtained and delivered to the Investor copies of all necessary permits, approvals,
and registrations necessary to effect this Agreement, the Transaction Documents and any of the transactions contemplated hereby or thereby,
including pursuant to Section 3.14 of this Agreement;


 


(c)
Trading Market Approval. The Company must have obtained and delivered to the Investor copies of all necessary Trading Market approvals
for the issuance of the Note, the Warrant, and, upon the conversion of the Note, the Conversion Shares, and upon exercise of the Warrant,
the Warrant Shares;


 


(d)
Full Satisfaction of the TD Bank Debt. The Company shall provide evidence to the Investor (such evidence to be reasonably satisfactory
to the Investor) that the Company has repaid in full all outstanding amounts owed under the TD Bank Debt, has terminated such TD Bank
Debt, and has obtained a satisfaction and release with respect thereto (including a release of any security interest thereunder);


 


(e)
No Event(s) of Default. The Investor must be of the reasonable opinion that no Event of Default has occurred and no Event of Default
would result from the execution of this Agreement or any of the Transaction Documents or the transactions contemplated hereby or thereby;


 


(f)
Representations and Warranties. The representations and warranties of the Company contained herein shall be true and correct in
all material respects as of the date when made and as of such Closing as though made on and as of such date;


 


(g)
Performance. The Company shall have performed, satisfied and complied in all material respects with all covenants, agreements
and conditions required by the Transaction Documents to be performed, satisfied or complied with by it at or prior to such Closing;


 


(h)
No Injunction. No statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered, promulgated
or endorsed by any court or governmental authority of competent jurisdiction that prohibits the consummation of any of the transactions
contemplated by the Transaction Documents;


 






    25 


     

    

 


(i)
No Suspensions of Trading in Common Shares; Listing. Trading in the Common Shares shall not have been suspended by the SEC or
any Trading Market (except for any suspensions of trading of not more than one day on which the Trading Market is open solely to permit
dissemination of material information regarding the Company) at any time since the date of execution of this Agreement, and the Common
Shares shall have been at all times since such date listed for trading on a Trading Market;


 


(j)
Limitation on Beneficial Ownership. To the Company’s knowledge, the issuance of the Note and the Warrant shall not cause
the Investor Group to become, directly or indirectly, a “beneficial owner” (within the meaning of Section 13(d) of the 1934
Act and the rules and regulations promulgated thereunder) of a number of Equity Interests of a class that is registered under the 1934
Act which exceeds the Maximum Percentage of the Equity Interests of such class that are outstanding at such time;


 


(k)
Perfection of Security Interest; Evidence of Lien Release. The Investor shall have, to its satisfaction, perfected the security
interest granted in the assets and collateral of the Company and its Subsidiaries described in the Security Documents; and


 


(l)
Funds Flow Request. The Company shall have delivered to the Investor a flow of funds request, substantially in the form set out
in Exhibit D.


 


6.2
Conditions Precedent to the Obligations of the Company. The obligation of the Company to issue the Note and the Warrant at
the Closing is subject to the satisfaction or waiver by the Company, at or before such Closing, of each of the following conditions:


 


(a)
Representations and Warranties. The representations and warranties of the Investor contained herein shall be true and correct
in all material respects as of the date when made and as of such Closing Date as though made on and as of such date;


 


(b)
Performance. The Investor shall have performed, satisfied and complied in all material respects with all covenants, agreements
and conditions required by the Transaction Documents to be performed, satisfied or complied with by the Investor at or prior to the Closing;
and


 


(c)
No Injunction. No statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered, promulgated
or endorsed by any court or governmental authority of competent jurisdiction that prohibits the consummation of any of the transactions
contemplated by the Transaction Documents.


 


7.
EVENTS OF DEFAULT


 


7.1
Events of Default. The occurrence of any of the following events shall be an “Event of Default” under this
Agreement:


 


(a)
an Event of Default under the Note;


 






    26 


     

    

 


(b)
any of the representations or warranties made by the Company, any Subsidiary or any of their agents, officers, directors, employees or
representatives in any Transaction Document or public filing being inaccurate, false or misleading in any material respect, as of the
date as of which it is made or deemed to be made, or any certificate or financial or other written statements furnished by or on behalf
of the Company or any Subsidiary to the Investor or any of its representatives, is inaccurate, false or misleading, in any material respect,
as of the date as of which it is made or deemed to be made, or on any Closing Date; or


 


(c)
a failure by the Company to comply with any of their covenants or agreements set forth in this Agreement, including those set forth in
Section 5.13 and Section 10.


 


7.2
Investor Right to Investigate an Event of Default. If in the Investor’s reasonable opinion, an Event of Default has
occurred, or is or may be continuing:


 


(a)
the Investor may notify the Company that is wishes to investigate such purported Event of Default;


 


(b)
the Company shall cooperate with the Investor in such investigation;


 


(c)
the Company shall comply with all reasonable requests made by the Investor to the Company in connection with any investigation by the
Investor and shall (i) provide all information requested by the Investor in relation to the Event of Default to the Investor; provided
that the Investor agrees that any materially price sensitive information and/or non-public information will be subject to confidentiality,
and (ii) provide all such requested information within five (5) Business Days of such request; and


 


(d)
the Company shall pay all reasonable costs incurred by the Investor in connection with any such investigation.


 


7.3
Remedies Upon an Event of Default


 


(a)
If an Event of Default occurs pursuant to Section 7.1(a), the Investor shall have such remedies as are set forth in the Note.


 


(b)
If an Event of Default occurs pursuant to Section 7.1(b) or Section 7.1(c) and is not remedied within (i) three (3)
Business Days for an Event of Default occurring by the Company’s or any Subsidiary’s failure to comply with Section 7.1(c),
or (ii) ten (10) Business Days for an Event of Default occurring pursuant to Section 7.1(b), the Investor may declare, by notice
to the Company or the applicable Subsidiary, as applicable, effective immediately, all outstanding obligations by the Company or the
applicable Subsidiary, as applicable, under the Transaction Documents to be immediately due and payable in immediately available funds
and the Investor shall have no obligation to consummate any Closing under this Agreement or to accept the conversion of the Note into
Conversion Shares.


 


(c)
If any Event of Default occurs and is not remedied within (i) three (3) Business Days for an Event of Default occurring by the Company’s
failure to comply with Section 7.1(c), or (ii) ten (10) Business Days for an Event of Default occurring pursuant to Section
7.1(b), the Investor may, by written notice to the Company, terminate this Agreement effective as of the date set forth in the Investor’s
notice.


 






    27 


     

    

 


8.
TERMINATION


 


8.1
Events of Termination. This Agreement:


 


(a)
may be terminated:


 


(i)
by the Investor on the occurrence or existence of a Securities Termination Event or a Change of Control pursuant to subsection (c) or
(d) contained in that definition;


 


(ii)
by the mutual written consent of the Company and the Investor, at any time;


 


(iii)
by either Party, by written notice to the other Party, effective immediately, if the Closing has not occurred within fifteen (15) Business
Days of the date of this Agreement or such later date as the Company and the Investor agree in writing, provided that the right to terminate
this Agreement under this Section 8.1(a)(iii) is not available to any party that is in material breach of or material default
under this Agreement or whose failure to fulfill any obligation under this Agreement has been the principal cause of, or has resulted
in the failure of the Closing to occur; or


 


(iv)
by the Investor, in accordance with Section 7.3(c).


 


8.2
Automatic Termination. This Agreement will automatically terminate, without further action by the parties, at the time after
the Closing that the Principal Amount outstanding under the Note and any accrued but unpaid interest is reduced to zero (0), whether
as a result of Conversion or repayment by the Company in accordance with the terms of this Agreement and the Note.


 


8.3
Effect of Termination.


 


(a)
Subject to Section 8.3(b), each party’s right of termination under Section 8.1 is in addition to any other rights
it may have under this Agreement or otherwise, and the exercise of a right of termination will not be an election of remedies.


 


(b)
If the Investor terminates this Agreement under Section 8.1(a)(i):


 


(i)
the Investor may declare, by notice to the Company, all outstanding obligations by the Company under the Transaction Documents to be
due and payable (including, without limitation, the immediate repayment of any Principal Amount outstanding under the Note plus accrued
but unpaid interest) without presentment, demand, protest or any other notice of any kind, all of which are expressly waived by the Company,
anything to the contrary contained in this Agreement or in any other Transaction Document notwithstanding; and


 


(ii)
the Company must within five (5) Business Days of such notice being received, pay to the Investor in immediately available funds the
outstanding Principal Amount for the Note plus all accrued interest thereon (if any), unless the Investor terminates this Agreement as
a result of an Event of Default and provided that (A) subsequent to the termination under Section 8.1(a)(i), the Investor is not
prohibited by Law or otherwise from exercising its conversion rights pursuant to this Agreement or the Note, (B) the Investor actually
exercises its conversion rights under this Agreement or the Note, and (C) the Company otherwise complies in all respects with its obligation
to issue Conversion Shares in accordance with the Note (which obligation will survive termination).


 






    28 


     

    

 


(c)
Upon termination of this Agreement, the Investor will not be required to fund any further amount after the date of termination of the
Agreement, provided that termination will not affect any undischarged obligation under this Agreement, and any obligation of the Company
to pay or repay any amounts owing to the Investor hereunder and which have not been repaid at the time of termination.


 


(d)
Nothing in this Agreement will be deemed to release any party from any liability for any breach by such party of the terms and provisions
of this Agreement or to impair the right of any party to compel specific performance by any other Party of its obligations under this
Agreement.


 


9.
REGISTRATION RIGHTS


 


9.1
Registration.


 


(a)
Registration Statement. Promptly, but in any event no later than forty-five (45) days following the Closing Date, the Company
shall prepare and file with the SEC a Registration Statement covering the resale of all of the Investor Shares. The foregoing Registration
Statement shall be filed on Form F-1 or a Form F-3 or any successor forms thereto. The Registration Statement (and each amendment or
supplement thereto, and each request for acceleration of effectiveness thereof) shall be provided to the Investor and its counsel at
least five (5) Business Days prior to its filing or other submission and the Company shall incorporate all reasonable comments provided
by the Investor or its counsel.


 


(b)
Expenses. Except as otherwise expressly provided herein, the Company will pay all fees and expenses incident to the performance
of or compliance with this Section 9, including all fees and expenses associated with effecting the registration of the Investor Shares,
including all filing and printing fees, the Company’s counsel and accounting fees and expenses, costs associated with clearing
the Investor Shares for sale under applicable state securities laws, listing fees, fees and expenses of one counsel to the Investor and
the Investor’s reasonable expenses in connection with the registration, but excluding discounts, commissions, fees of underwriters,
selling brokers, dealer managers or similar securities industry professionals with respect to the Investor Shares being sold.


 


(c)
Effectiveness. The Company shall use its best efforts to have the Registration Statement declared effective as soon as practicable
after filing thereof but in no event later than one hundred and twenty (120) days following the Closing Date. The Company shall notify
the Investor by e-mail as promptly as practicable, and in any event, within twenty-four (24) hours, after the Registration Statement
is declared effective and shall simultaneously provide the Investor with copies of any related Prospectus to be used in connection with
the sale or other disposition of the securities covered thereby.


 






    29 


     

    

 


(d)
Piggyback Registration Rights. If the Company at any time determines to file a registration statement under the 1933 Act to register
the offer and sale, by the Company, of Common Stock (other than (x) on Form S-4 or Form S-8 under the 1933 Act or any successor forms
thereto, (y) an at-the-market offering, or (z) a registration of securities solely relating to an offering and sale to employees or directors
of the Company pursuant to any employee stock plan or other employee benefit plan arrangement), the Company shall, as soon as reasonably
practicable, give written notice to each Investor of its intention to so register the offer and sale of Com-mon Stock and, upon the written
request, given within five (5) Business Days after delivery of any such notice by the Company, of an Investor to include in such registration
its Investor Shares (which request must (a) be approved by the Requisite Holders and (b) specify the number of Investor Shares proposed
to be included in such registration), the Company shall cause all such Investor Shares to be included in such registration statement
on the same terms and conditions as the Common Stock otherwise being sold pursuant to such registered offering.


 


9.2
Company Obligations. The Company will use its best efforts to effect the registration of the Investor Shares in accordance
with the terms hereof, and pursuant thereto the Company will, as expeditiously as possible:


 


(a)
use its commercially reasonable efforts to cause the Registration Statement to become effective and to remain continuously effective
for a period that will terminate upon the first date on which all Investor Shares are either covered by the Registration Statement or
may be sold without restriction, including volume or manner-of-sale restrictions, pursuant to Rule 144 or have been sold by the Investor
(the “Effectiveness Period”) and advise the Investor in writing when the Effectiveness Period has expired;


 


(b)
prepare and file with the SEC such amendments and post-effective amendments and supplements to the Registration Statement and the Prospectus
as may be necessary to keep the Registration Statement effective for the Effectiveness Period and to comply with the provisions of the
1933 Act and the 1934 Act with respect to the distribution of all of the Investor Shares covered thereby;


 


(c)
provide copies to and permit counsel designated by the Investor to review all amendments and supplements to the Registration Statement
no fewer than three (3) Business Days prior to its filing with the SEC and not file any document to which such counsel reasonably objects;


 


(d)
furnish to the Investor and its legal counsel, without charge, (i) promptly after the same is prepared and publicly distributed, filed
with the SEC, or received by the Company (but not later than two (2) Business Days after the filing date, receipt date or sending date,
as the case may be) one copy of the Registration Statement and any amendment thereto, each preliminary prospectus and Prospectus and
each amendment or supplement thereto, and each letter written by or on behalf of the Company to the SEC or the staff of the SEC, and
each item of correspondence from the SEC or the staff of the SEC, in each case relating to the Registration Statement (other than any
portion of any thereof which contains information for which the Company has sought confidential treatment), and (ii) such number of copies
of a Prospectus, including a preliminary prospectus, and all amendments and supplements thereto and such other documents as the Investor
may reasonably request in order to facilitate the disposition of the Investor Shares that are covered by the related Registration Statement;


 






    30 


     

    

 


(e)
immediately notify the Investor of any request by the SEC for the amending or supplementing of the Registration Statement or Prospectus
or for additional information;


 


(f)
use its commercially reasonable efforts to (i) prevent the issuance of any stop order or other suspension of effectiveness and, (ii)
if such order is issued, obtain the withdrawal of any such order at the earliest possible moment and notify the Company of the issuance
of any such order and the resolution thereof, or its receipt of notice of the initiation or threat of any proceeding for such purpose;


 


(g)
prior to any public offering of Investor Shares, use its commercially reasonable efforts to register or qualify or cooperate with the
Investor and its counsel in connection with the registration or qualification of such Investor Shares for offer and sale under the securities
or blue sky laws of such jurisdictions requested by the Investor and do any and all other commercially reasonable acts or things necessary
or advisable to enable the distribution in such jurisdictions of the Investor Shares covered by the Registration Statement and the Company
shall promptly notify the Investor of any notification with respect to the suspension of the registration or qualification of any of
such Investor Shares for sale under the securities or blue sky laws of such jurisdictions or its receipt of notice of the initiation
or threat of any proceeding for such purpose;


 


(h)
immediately notify the Investor, at any time prior to the end of the Effectiveness Period, upon discovery that, or upon the happening
of any event as a result of which, the Registration Statement or Prospectus includes an untrue statement of a material fact or omits
to state any material fact required to be stated therein or necessary to make the statements therein not misleading (in the case of the
Prospectus, in light of the circumstances in which they were made), and promptly prepare, file with the SEC and furnish to such holder
a supplement to or an amendment of such Registration Statement or Prospectus as may be necessary so that such Registration Statement
or Prospectus shall not include an untrue statement of a material fact or omit to state a material fact required to be stated therein
or necessary to make the statements therein not misleading (in the case of such Prospectus, in light of the circumstances in which they
were made);


 


(i)
otherwise use its commercially reasonable efforts to comply with all applicable rules and regulations of the SEC under the 1933 Act and
the 1934 Act;


 


(j)
hold in confidence and not make any disclosure of information concerning the Investor provided to the Company unless (i) disclosure of
such information is necessary to comply with federal or state securities laws, (ii) the disclosure of such information is necessary to
complete the Registration Statement or to avoid or correct a misstatement or omission in the Registration Statement, (iii) the release
of such information is ordered pursuant to a subpoena or other final, non-appealable order from a court or governmental body of competent
jurisdiction, or (iv) such information has been made generally available to the public other than by disclosure in violation of this
Agreement or any other agreement, and upon learning that disclosure of such information concerning the Investor is sought in or by a
court or governmental body of competent jurisdiction or through other means, give prompt written notice to the Investor and allow the
Investor, at the Investor’s expense, to undertake appropriate action to prevent disclosure of, or to obtain a protective order
for, such information; and


 






    31 


     

    

 


(k)
take all other reasonable actions necessary to expedite and facilitate disposition by the Investor of all Investor Shares pursuant to
the Registration Statement.


 


9.3
Indemnification.


 


(a)
Indemnification by the Company. The Company will indemnify and hold harmless the Investor Parties, from and against any Losses
to which they may become subject under the 1933 Act or otherwise, arising out of, relating to or based upon: (i) any untrue statement
or alleged untrue statement of any material fact contained in any Registration Statement, any preliminary prospectus, final Prospectus
or other document, including any blue sky application (as defined below), or any amendment or supplement thereof or any omission or alleged
omission of a material fact required to be stated therein or, in the case of the Registration Statement, necessary to make the statements
therein not misleading or, in the case of any preliminary prospectus, final Prospectus or other document, necessary to make the statements
therein, in light of the circumstances in which they were made, not misleading; (ii) any blue sky application or other document executed
by the Company specifically for that purpose or based upon written information furnished by the Company filed in any state or other jurisdiction
in order to qualify any or all of the Investor Shares under the securities laws thereof (any such application, document or information
herein called a “Blue Sky Application”); (iii) any violation or alleged violation by the Company or its agents of
the 1933 Act, the 1934 Act or any similar federal or state law or any rule or regulation promulgated thereunder applicable to the Company
or its agents and relating to any action or inaction required of the Company in connection with the registration or the offer or sale
of the Investor Shares pursuant to any Registration Statement; or (iv) any failure to register or qualify the Investor Shares included
in any such Registration Statement in any state where the Company or its agents has affirmatively undertaken or agreed in writing that
the Company will undertake such registration or qualification on the Investor’s behalf and will reimburse the indemnified Investor
Parties for any legal or other expenses reasonably incurred by them in connection with investigating, preparing or defending any such
Losses; provided, however, that the Company will not be liable in any such case if and to the extent, but only to the extent,
that any such Losses arise out of or are based upon an untrue statement or alleged untrue statement or omission or alleged omission so
made in conformity with information furnished by the Investor or any such controlling Person in writing specifically for use in such
Registration Statement or Prospectus.


 


(b)
Conduct of Indemnification Proceedings. Any Person entitled to indemnification hereunder shall (i) give prompt notice to the indemnifying
party of any claim, action, suit or proceeding with respect to which it seeks indemnification following such Person’s receipt of,
or such Person otherwise becoming aware of, the commencement of such claim, action, suit or proceeding and (ii) permit such indemnifying
party to assume the defense of such claim, action, suit or proceeding with counsel reasonably satisfactory to the indemnified party;
provided, however, that any Person entitled to indemnification hereunder shall have the right to employ separate counsel
and to participate in the defense of such claim, but the fees and expenses of such counsel shall be at the expense of such Person unless
(A) the indemnifying party has agreed to pay such fees or expenses, (B) the indemnifying party shall have failed to assume the defense
of such claim and employ counsel reasonably satisfactory to such Person or (C) in the reasonable judgment of any such Person, based upon
written advice of its counsel, a conflict of interest exists between such Person and the indemnifying party with respect to such claims
(in which case, if the Person notifies the indemnifying party in writing that such Person elects to employ separate counsel at the expense
of the indemnifying party, the indemnifying party shall not have the right to assume the defense of such claim on behalf of such Person);
and provided, further, that the failure or delay of any indemnified party to give notice as provided herein shall not relieve
the indemnifying party of its obligations hereunder, except to the extent that such failure or delay to give notice shall materially
adversely affect the indemnifying party in the defense of any such claim or litigation. It is understood that the indemnifying party
shall not, in connection with any proceeding in the same jurisdiction, be liable for fees or expenses of more than one separate firm
of attorneys at any time for all such indemnified parties. No indemnifying party will, except with the consent of the indemnified party,
consent to entry of any judgment or enter into any settlement that does not include as an unconditional term thereof the giving by the
claimant or plaintiff to such indemnified party of a release from all liability in respect of such claim or litigation.


 






    32 


     

    

 


(c)
Contribution. If for any reason the indemnification provided for in the preceding paragraph (a) is unavailable to an indemnified
party or insufficient to hold it harmless, other than as expressly specified therein, the indemnifying party shall contribute to the
amount paid or payable by the indemnified party as a result of such Losses in such proportion as is appropriate to reflect the relative
fault of the indemnified party and the indemnifying party, as well as any other relevant equitable considerations. No Person guilty of
fraudulent misrepresentation within the meaning of Section 11(f) of the 1933 Act shall be entitled to contribution from any Person not
guilty of such fraudulent misrepresentation. The indemnity and contribution agreements contained in this Section are in addition to any
other rights or remedies that any indemnified party may have under applicable law, by separate agreement or otherwise.


 


10.
RIGHTS TO FUTURE SHARE ISSUANCES.
Subject to the terms and conditions of this Section 10 and applicable securities laws, if at any time prior to the first anniversary
of the Closing, the Company proposes to offer or sell any New Securities, the Company shall first offer the Investor the opportunity
to purchase up to ten percent (10%) of such New Securities. The Investor shall be entitled to apportion the right of first offer hereby
granted to it in such proportions as it deems appropriate among itself and its Affiliates.


 


10.1
The Company shall give notice (the “Offer Notice”) to the Investor, stating (a) its bona fide intention to offer
such New Securities, (b) the number of such New Securities to be offered, and (c) the price and terms, if any, upon which it proposes
to offer such New Securities.


 


10.2
By notification to the Company within ten (10) days after the Offer Notice is given, the Investor may elect to purchase or otherwise
acquire, at the price and on the terms specified in the Offer Notice, up to ten percent (10%) of such New Securities. The closing of
any sale pursuant to this Section 10 shall occur within the later of ninety (90) days of the date that the Offer Notice is given
and the date of initial sale of New Securities pursuant to Section 10.3.


 


10.3
The Company may, during the ninety (90) day period following the expiration of the period provided in Section 10.2, offer
and sell the remaining portion of such New Securities to any Person or Persons at a price not less than, and upon terms no more favorable
to the offeree than, those specified in the Offer Notice. If the Company does not enter into an agreement for the sale of the New Securities
within such period, or if such agreement is not consummated within thirty (30) days of the execution thereof, the right provided hereunder
shall be deemed to be revived and such New Securities shall not be offered unless first reoffered to the Investors in accordance with
this Section 10.


 






    33 


     

    

 


10.4
The right of first offer in this Section 10 shall not be applicable to Exempted Securities, or any New Securities registered
for sale under the 1933 Act.


 


11.
GENERAL PROVISIONS


 


11.1
Fees and Expenses. Prior to the date of this Agreement, the Company has paid Morgan, Lewis & Bockius LLP (“Morgan
Lewis”) $25,000. At the Closing, the Company shall reimburse the Investor up to an additional $50,000 of due diligence costs
and reasonable fees and disbursements of Morgan Lewis and Stikeman Elliott LLP (“Stikeman” and together with Morgan
Lewis, “Investor Counsel”) in connection with the preparation of the Transaction Documents, it being understood that
Investor Counsel has not rendered any legal advice to the Company in connection with the transactions contemplated hereby and that the
Company has relied for such matters on the advice of its own counsel. All fees to be paid referenced above shall be offset against the
Funding Amount of the Investor and paid directly by the Investor to Investor Counsel. Following the Closing, the Company shall reimburse
the Investor for all reasonable fees and disbursements of Investor Counsel in connection with any additional agreements arising pursuant
to the transactions contemplated in this Agreement, including, but not limited to, intercreditor agreements relating to the Note and
any agreements or documentation required with respect to the Investor’s exercise of any of its rights hereunder. Except as specified
above, each party shall pay the fees and expenses of its advisers, counsel, accountants and other experts, if any, and all other expenses
incurred by such party incident to the negotiation, preparation, execution, delivery and performance of the Transaction Documents. The
Company shall pay all stamp and other Taxes and duties levied in connection with the sale of the Note and the Warrant.


 


11.2
Notices. Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be
in writing and shall be deemed given and effective on the earliest of (a) the date of transmission, if such notice or communication is
delivered via email at the email address specified in this Section prior to 5:00 p.m. (New York time) on a Business Day, (b) the next
Business Day after the date of transmission, if such notice or communication is delivered via email at the email address specified in
this Section on a day that is not a Business Day or later than 5:00 p.m. (New York time) on any date and earlier than 11:59 p.m. (New
York time) on such date, (c) the Business Day following the date of mailing, if sent by U.S. nationally recognized overnight courier
service, or (d) upon actual receipt by the party to whom such notice is required to be given. The address for such notices and communications
shall be as follows:


 


If
to the Company:


 


Siyata
Mobile Inc.

2200 – 885 West Georgia Street

Vancouver, British Columbia, Canada V6C 3E8

Telephone: (514) 500-1181

Email: marc@siyata.net


Attention:
Marc Seelenfreund, CEO


 






    34 


     

    

 


With
a copy (which shall not constitute notice) to:


 


McCarter
& English, LLP


Worldwide
Plaza


825
Worldwide Plaza


New
York, NY 10019


Telephone:
(212) 609-6862


Email:
pgennuso@mccarter.com


Attention:
Peter J. Gennuso


 


Cassels
Brock & Blackwell LLP


2200
– 885 West Georgia Street


Vancouver,
British Columbia, Canada V6C 3E8


E-Mail:
jdurno@cassels.com


Attention:
Jeff Durno


 


If
to the Investor:


 


Lind
Global Fund II LP

c/o The Lind Partners LLC

444 Madison Avenue, Floor 41

New York, NY 10022

Telephone: (646) 395-3931

Email: jeaston@thelindpartners.com and


notice@thelindpartners.com

Attention: Jeff Easton


 


With
a copy (which shall not constitute notice) to:


 


Morgan,
Lewis & Bockius LLP

One Federal Street

Boston, MA 02110

Telephone: (617) 341-7269

Email: bryan.keighery@morganlewis.com

Attention: Bryan S. Keighery


 


Stikeman
Elliott LLP


Suite
1700


666
Burrad Street


Vancouver,
British Columbia V6C 2X8


Telephone:
(604) 631-1408


Email:
vgerchikov@stikeman.com


Attention:
Victor Gerchikov


 


or
such other address as may be designated in writing hereafter, in the same manner, by such Person.


 






    35 


     

    




 


11.3
Severability. If any provision of this Agreement is held by a court of competent jurisdiction to be excessive in scope or
otherwise invalid or unenforceable, such provision shall be adjusted rather than voided, if possible, so that it is enforceable to the
maximum extent possible, and the validity and enforceability of the remaining provisions of this Agreement will not in any way be affected
or impaired thereby.


 


11.4
Governing Law. This Agreement shall be governed by and construed in accordance with the Laws of the State of New York, without
reference to principles of conflict of laws or choice of laws.


 


11.5
Jurisdiction and Venue. Any action, proceeding or claim arising out of, or relating in any way to this Agreement shall be
brought and enforced in the New York Supreme Court, County of New York, or in the United States District Court for the Southern District
of New York. The Company and the Investor irrevocably submit to the jurisdiction of such courts, which jurisdiction shall be exclusive,
and hereby waive any objection to such exclusive jurisdiction or that such courts represent an inconvenient forum. The prevailing party
in any such action shall be entitled to recover its reasonable and documented attorneys’ fees and out-of-pocket expenses relating
to such action or proceeding.


 


11.6
WAIVER OF RIGHT TO JURY TRIAL. THE COMPANY AND THE INVESTOR HEREBY IRREVOCABLY WAIVE, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE
LAW, ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE OTHER TRANSACTION
DOCUMENTS.


 


11.7
Survival. The representations, warranties, agreements and covenants contained herein shall survive the Closing and the delivery
of the Securities.


 


11.8
Entire Agreement. The Transaction Documents, together with the Exhibits and Schedules thereto, contain the entire understanding
of the parties with respect to the subject matter hereof and supersede all prior agreements and understandings, oral or written, with
respect to such matters, which the parties acknowledge have been merged into such documents, exhibits and schedules.


 


11.9
Amendments; Waivers. No provision of this Agreement may be waived or amended except in a written instrument signed by the
Company and the Investor. No waiver of any default with respect to any provision, condition or requirement of this Agreement shall be
deemed to be a continuing waiver in the future or a waiver of any subsequent default or a waiver of any other provision, condition or
requirement hereof, nor shall any delay or omission of either party to exercise any right hereunder in any manner impair the exercise
of any such right.


 


11.10
Construction. The headings herein are for convenience only, do not constitute a part of this Agreement and shall not be deemed
to limit or affect any of the provisions hereof. The language used in this Agreement will be deemed to be the language chosen by the
parties to express their mutual intent, and no rules of strict construction will be applied against any party. This Agreement shall be
construed as if drafted jointly by the parties, and no presumption or burden of proof shall arise favoring or disfavoring any party by
virtue of the authorship of any provisions of this Agreement or any of the Transaction Documents.


 






    36 


     

    

 


11.11
Successors and Assigns. This Agreement shall be binding upon, and inure to the benefit of and be enforceable by, the Company
and the Investor and their respective successors and assigns. The Company may not assign this Agreement or any rights or obligations
hereunder without the prior written consent of the Investor. The Investor may assign any or all of its rights under this Agreement to
any Person to whom the Investor assigns or transfers any Securities, provided such transferee agrees in writing to be bound, with respect
to the transferred Securities, by the provisions hereof that apply to the “Investor” and such transferee is an accredited
investor.


 


11.12
No Third-Party Beneficiaries. This Agreement is intended for the benefit of the parties hereto and their respective successors
and permitted assigns and is not for the benefit of, nor may any provision hereof be enforced by, any other Person.


 


11.13
Further Assurances. Each party hereto shall do and perform, or cause to be done and performed, all such further acts and things,
and shall execute and deliver all such other agreements, certificates, instruments and documents, as the other party may reasonably request
in order to carry out the intent and accomplish the purposes of this Agreement and the consummation of the transactions contemplated
hereby.


 


11.14
Counterparts. This Agreement may be executed in two identical counterparts, both of which shall be considered one and the
same agreement and shall become effective when counterparts have been signed by each party and delivered to the other party. Signature
pages delivered by facsimile or e-mail shall have the same force and effect as an original signature.


 


11.15
Specific Performance. The Company acknowledges that monetary damages alone would not be adequate compensation to the Investor
for a breach by the Company of this Agreement and the Investor may seek an injunction or an order for specific performance from a court
of competent jurisdiction if (a) the Company fails to comply or threatens not to comply with this Agreement or (b) the Investor has reason
to believe that the Company will not comply with this Agreement.


 


[Signature
Page Follows]


 






    37 


     

    

 


IN
WITNESS WHEREOF, the undersigned have executed this Securities Purchase Agreement as of the date first set forth above.


 





	COMPANY:	 	INVESTOR:
	 	 	 
	SIYATA MOBILE
    INC.	 	Lind
    GLOBAL FUND II LP
	 	 	 
	By:	 	 	By:	 
	Name:	Marc Seelenfreund	 	Name:	Jeff Easton
	Title: 	Chief Executive Officer	 	Title:	Managing Member of Lind Global Partners II LLC,

 General
    Partner





 


[Signature Page of Securities Purchase Agreement]





 




    38 


     

    

 


EXHIBIT
A


 


SECURITY
DOCUMENTS


 


A
guarantee agreement dated as of the date hereof of Siyata Mobile (Canada) Inc., Queensgate Resources Corp., Siyata Mobile Israel Ltd.
and Signifi Mobile Inc., as guarantors, in favour of the Investor


 


A
guaranty dated as of the date hereof from ClearRF Nevada Inc. and Clear RF LLC, as guarantors, in favor of the Investor


 


A
security agreement dated as of the date hereof granted by the Company, Siyata Mobile (Canada) Inc., Queensgate Resources Corp., and Siyata
Mobile Israel Ltd., as obligors, in favour of the Investor, as secured creditor


 


A
hypothec on movables granted by Signifi Mobile Inc., as grantor, in favour of the Investor, as creditor


 


A
security agreement dated as of the date hereof by and between the Company and the Investor.


 


A
security agreement dated as of the date hereof by and among ClearRF Nevada Inc.,Clear RF LLC, and the Investor


 


A
Stock Pledge Agreement dated as of the date hereof by and between Signifi Mobile Inc. and the Investor.


 


A
Pledge Agreement dated as of the date hereof by and between ClearRF Nevada Inc. and the Investor


 


Any
other security document reasonably requested by the Investor from time to time from an Obligor


 




    39 


     

    

 


EXHIBIT
B


 


FORM
OF NOTE


 


[See
attached]


 




    40 


     

    

 


EXHIBIT
C


 


FORM
OF WARRANT


 


[See
attached]


 




    41 


     

    

 


EXHIBIT
D


 


FLOW
OF FUNDS REQUEST


 


 


42